Practice patterns in the timing of antenatal corticosteroids for fetal lung maturity

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 28, Issue 13, 2015, Pages 1598-1601

  Adams, Tracy M ^a,b   Kinzler, Wendy L ^b   Chavez, Martin R ^b   Fazzari, Melissa J ^b   Vintzileos, Anthony M ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Antenatal corticosteroids; decision to administer antenatal corticosteroids; timing of antenatal corticosteroids

Indexed keywords

BETAMETHASONE; CORTICOSTEROID;

ADULT; ARTICLE; CERVICAL LENGTH MEASUREMENT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FEMALE GENITAL TRACT PARAMETERS; FETUS LUNG MATURATION; GESTATIONAL AGE; GYNECOLOGICAL EXAMINATION; HUMAN; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRENATAL PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; TIME TO TREATMENT; TOCOLYSIS; TWIN PREGNANCY; UTERINE CERVIX DILATATION; UTERUS CONTRACTION; VAGINA BLEEDING; CLINICAL PRACTICE; DRUG ADMINISTRATION; DRUG EFFECTS; EMBRYOLOGY; FETUS MATURITY; LUNG; NEWBORN; OBSTETRIC LABOR, PREMATURE; PREGNANCY; STATISTICS AND NUMERICAL DATA; TIME FACTOR; YOUNG ADULT;

ADRENAL CORTEX HORMONES; ADULT; BETAMETHASONE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FETAL ORGAN MATURITY; HUMANS; INFANT, NEWBORN; LUNG; OBSTETRIC LABOR, PREMATURE; PRACTICE PATTERNS, PHYSICIANS'; PREGNANCY; RETROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 84941212052     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2014.962508     Document Type: Article

References (18)

1. Hamilton BE, Hoyert DL, Martin JA, et al. Annual summary of vital statistics: 2010-2011. Pediatrics 2013;131:548-58.
2. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50:515-25.
3. ACOG Committee on Obstetric Practice. Antenatal corticosteroid therapy for fetal maturation. Committee Opinion No. 475. American College of Obstetricians and Gynecologists. Obstet Gynecol 2011;117:422-4.
4. Vis JY, Wilms FF, Kuin RA. Time to delivery after the first course of antenatal corticosteroids. Am J Perinatol 2011;28:683-8.
5. Murphy KE, Hannah ME, Willan AR, et al. Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial. Lancet 2008;372:2143-51.
6. Wapner R, Sorokin Y, Thom E, et al. Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. Am J Obstet Gynecol 2006;195:633-42.
7. Garite TJ, Kurtzman J, Maurel K, Clark R. Impact of a 'rescue course' of antenatal corticosteroids: a multicenter randomized placebo controlled trial. Am J Obstet Gynecol 2009;200:248. e1-9.
8. Ring AM, Garland JS, Stafeil BR, et al. The effect of a prolonged time interval between antenatal corticosteroid administration and delivery on outcome in preterm neonates: a cohort study. Am J Obstet Gynecol 2007;196:457.e1-66.
9. McEvoy C, Schilling D, Spitale P, et al. Decreased respiratory compliance in infants less than or equal to 32 weeks gestation delivered more than 7 days after antenatal steroid therapy. Pediatrics 2008;121:e1032-8.
10. Peaceman A, Bajaj K, Kumar P, Grobman WA. The interval between a single course of antenatal steroids and delivery and its association with neonatal outcomes. Am J Obstet Gynecol 2005;193:1165-9.
11. Wilms FF, Vis JY, Pattinaja DA, et al. Relationship between the time interval from antenatal corticosteroid administration until preterm birth and the occurrence of respiratory morbidity. Am J Obsetet Gynecol 2011;205:49.e1-7.
12. Elimian A, Figueroa R, Spitzer AR, et al. Antenatal corticosteroids: are incomplete courses beneficial? Obstet Gynecol 2003;102:352-5.
13. SanyaR, Al Naggar E, Gasim M, Ahmed BI. Use or overuse of antenatal corticosteroids for suspected preterm birth. J Matern Fetal Neonatal Med 2014;27:1454-6.
14. Boseveld M, Heida K, Oudijk MA, et al. Evaluation of antenatal corticosteroid prescribing patterns among 984 women at risk for preterm delivery. J Matern Fetal Neonatal Med 2014;27:516-9.
15. Honest H, Bachmann LM, Gupta JK, et al. Accuracy of cervocovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review. BMJ 2002;325:301.
16. Honest H, Bachmann LM, Coomarasamy A, et al. Accuracy of transvaginal sonography in predicting preterm birth: a systematic review. Ultrasound Obstet Gynecol 2003;22:305-22.
17. Gomez R, Romero R, Medina L, et al. Cervicovaginal fibronectin improves the prediction of preterm delivery based on sonographic cervical length in patients with preterm uterine contractions and intact membranes. Am J Obstet Gynecol 2005;192:350-9.
18. Schmitz T, Maillard F, Bessard-Bacquaert M, et al. Selective use of fetal fibronectin detection after cervical length measurement to predict spontaneous preterm delivery in women with preterm labor. Am J Obstet Gynecol 2006;194:138-43.